We are launching Syvazul BTV, a vaccine for the bluetongue virus

Syvazul® BTV is the first vaccine registered by Laboratorios Syva through the EU centralised registration procedure. Marketing approval was issued on 9th January 2019.
The vaccine is presented in the form of injectable suspension and is indicated for:
- Active immunization of ovine livestock to prevent viraemia and reduce the clinical signs and lesions caused by serotypes 1 and/or 8 of the bluetongue virus or to reduce viraemia and the clinical signs and lesions caused by bluetongue virus serotype 4.
- Active immunization of bovine livestock to prevent viraemia caused by serotypes 1 and/or 8 of the bluetongue virus or to reduce viraemia* caused by serotype 4 of bluetongue virus.
The most important advantage of Syvazul® BTV is its flexible use as a monovalent or combined vaccine. In this latter case, the product will contain a maximum of two of the three inactivated virus strains mentioned above, which will enable two strains to be vaccinated in just one injection.
Sheep can be vaccinated subcutaneously from 3 months of age. Cows can be vaccinated via the intramuscular route from 2 months of age. Vaccination can be performed during gestation and breastfeeding.
The recommendation for vaccination is as follows:
Sheep:
-First vaccination: administer a single 2 mL dose.
-Repeat vaccination: administer one 2 mL dose after 12 months.
Cows:
– First vaccination: administer two 4 mL doses 3 weeks apart.
– Repeat vaccination: administer one 4 mL dose after 12 months.
Syvazul® BTV is available in polypropylene vials that contain 80 and 200 mL.
See the specifications: https://syva.es/producto/syvazul-btv-suspension-inyectable/
You may also be interested in

30 August, 2023
New tool for controlling erysipelas and PPV: Syvac® Ery Parvo
Because every farm is unique, it needs individualised protocols for swine erysipela and PPV control. Failing to control erysipelas and PPV throughout a sow's life can lead to a host of problems that are difficult to control and have a direct impact on production.

19 July, 2023
Interview with Inés Ruedas, winner of the Syva Award 2023 – Tierras Porcino
We could not miss this excellent interview, conducted by Interempresas for Tierras Porcino, which recently interviewed our Syva 2022 award winner, Inés Ruedas Torres, about her thesis and the numerous challenges that the pig sector faces in the fight against PRRSV. In her interview, Inés speaks about the new advances in the fight against this disease, but also about the...

2 March, 2023
SYVA announces its partnership with the biotech SMIVET for the development of SDA [SDA]
León - Technology Park – Spain, March 2, 2023 - SYVA and SMIVET signed a collaboration agreement that allow both companies to develop therapeutic solutions based on Single Domain Antibodies (SDA). With this agreement, Syva expresses its willingness to invest in new biotechnologies with the objective to continue to grow and improve its attractiveness by researching, developing, and producing...